Ultragenyx Announces Submission of New Drug Application to FDA for UX007 (triheptanoin) for Treatment of Long-Chain Fatty Acid Oxidation Disorders August 1, 2019 - NASDAQ Companies 0 » View More News for August 01, 2019
